Latest / Morning Medical with Dr. Chow / Compounded Semaglutide Concerns, Sleep & Dementia, and Healthcare Post-Election

Transcript

Compounded Semaglutide Concerns, Sleep & Dementia, and Healthcare Post-Election · Morning Medical with Dr. Chow

• 0:00
  Welcome to Morning Medical with Dr.
• 0:01
  Chow.
• 0:02
  I'm your host, Dr.
• 0:04
  Chi-Ming Chow, bringing you the latest updates in medical and health news from around the
• 0:08
  world.
• 0:09
  Today, we're diving into a concerning development involving compounded semaglutide, a
• 0:15
  drug many might recognize as the active ingredient in diabetes and obesity medications
• 0:20
  like Ozempic and Wegovy.
• 0:25
  Recently, compounded versions of semaglutide have been linked to a troubling number of
• 0:29
  hospitalizations and deaths.
• 0:31
  Specifically, Novo Nordisk, the company behind Ozempic, has reported at least 100
• 0:36
  hospitalizations and 10 deaths in connection with these compounded drugs.
• 0:43
  Lars Fruergaard Jorgensen, the President and Chief Executive Officer of Novo Nordisk,
• 0:48
  expressed his alarm over the situation, emphasizing that patients might believe they're
• 0:53
  receiving the safe, FDA-approved semaglutide, but in reality, they could be getting something
• 0:59
  entirely different.
• 1:01
  Jorgensen stated, "I know for a fact that they are not getting semaglutide, because there’s
• 1:07
  only one semaglutide, and that’s produced by Novo Nordisk."
• 1:12
  The data supporting these claims comes from the United States Food and Drug Administration’s
• 1:16
  adverse event reporting database.
• 1:19
  However, it's important to note that these reports aren't verified, which means the drugs
• 1:25
  haven't been definitively linked to the harms documented.
• 1:29
  The FDA has not provided a comment on the reports yet, but the agency has previously
• 1:34
  warned about the potential risks associated with compounded drugs, especially those not
• 1:39
  closely regulated or FDA-approved.
• 1:43
  Compounded drugs are typically produced by pharmacies or manufacturers other than the
• 1:48
  original drug makers, often allowed during drug shortages.
• 1:52
  Semaglutide, along with a similar drug, tirzepatide, has been on the FDA’s shortages
• 1:58
  list since 2022.
• 2:01
  The popularity of these GLP-1 receptor agonists led to a surge in compounded versions, raising
• 2:07
  concerns due to their lack of stringent regulation.
• 2:11
  The FDA has received multiple reports of adverse events, some requiring hospitalization,
• 2:17
  that might be linked to dosing errors with compounded injectable semaglutide products.
• 2:23
  There's also a risk of counterfeit forms of Ozempic being sold, as well as compounded
• 2:28
  versions using salt forms of semaglutide, which differ from the approved drugs.
• 2:33
  Interestingly, the shortage of tirzepatide, known as Mounjaro for diabetes and Zepbound for
• 2:38
  obesity, was recently declared resolved by the FDA, which could potentially end the mass
• 2:43
  compounding of the drug.
• 2:45
  However, due to ongoing litigation, the FDA is re-evaluating this decision.
• 2:49
  Meanwhile, semaglutide remains on the shortages list, though Novo Nordisk is hopeful this will
• 2:54
  change soon, as the last dose of Wegovy in short supply is now available.
• 3:00
  Novo Nordisk is actively collaborating with the FDA to address these issues.
• 3:05
  Jorgensen is hopeful that both parties can find a resolution that prioritizes patient safety.
• 3:11
  The FDA is currently assessing whether the demand for semaglutide in the United States
• 3:16
  surpasses the available supply, a determination that will impact future decisions regarding
• 3:21
  compounding practices.
• 3:24
  The adverse event database for semaglutide has recorded 10 deaths potentially linked to
• 3:29
  compounded semaglutide since 2023.
• 3:32
  Additionally, there are nearly 500 other deaths associated with semaglutide not flagged as
• 3:38
  related to compounding.
• 3:39
  However, the FDA cautions that these reports, provided by consumers and healthcare
• 3:44
  professionals, have limitations.
• 3:47
  They may contain duplicates or incomplete information, and the presence of a drug in a
• 3:52
  report doesn't necessarily mean it caused the adverse event.
• 3:57
  Feeling sleepy during the day might be more than just an inconvenience, especially for
• 4:02
  older adults.
• 4:04
  A recent study has found that daytime sleepiness could indicate a higher risk for
• 4:10
  developing conditions leading to dementia.
• 4:14
  This research, published in the journal Neurology, highlights a significant link
• 4:19
  between excessive daytime sleepiness and motoric cognitive risk syndrome, or MCR.
• 4:26
  In the study, 35.5% of participants who experienced excessive daytime sleepiness and a
• 4:32
  lack of enthusiasm developed MCR, compared to just 6.7% of those without these problems.
• 4:39
  Motoric cognitive risk syndrome is characterized by slow walking speed and memory
• 4:44
  complaints among older adults who do not already have dementia or mobility disabilities.
• 4:49
  The risk of developing dementia more than doubles for those with this syndrome.
• 4:54
  First described in 2013, MCR highlights the importance of early intervention, as
• 5:00
  researchers believe addressing sleep dysfunction could potentially prevent dementia.
• 5:05
  The study involved 445 adults with an average age of 76, recruited from Westchester County,
• 5:12
  New York, for the Central Control of Mobility and Aging study.
• 5:18
  Over a period from 2011 to 2018, participants were assessed annually, with their walking
• 5:24
  speed recorded and their sleep quality evaluated using the Pittsburgh Sleep Quality
• 5:29
  Index.
• 5:30
  This index measures subjective sleep quality, the time it takes to fall asleep, sleep
• 5:35
  duration, sleep efficiency, disturbances, medication use, and daytime dysfunction, such
• 5:41
  as difficulty staying awake during activities or reduced enthusiasm.
• 5:46
  Interestingly, while poor sleepers had only a slightly higher risk of developing MCR overall,
• 5:52
  daytime dysfunction specifically was linked to a 3.3 times higher risk of MCR.
• 5:58
  This finding suggests that daytime sleepiness might be a more significant predictor of
• 6:02
  cognitive decline than other sleep quality components.
• 6:06
  Dr.
• 6:07
  Richard Isaacson, director of research at the Institute for Neurodegenerative Diseases in
• 6:12
  Florida, who was not involved in the study, emphasized the importance of asking about sleep
• 6:17
  patterns and considering walking speed when diagnosing early cognitive issues.
• 6:23
  However, the study does have limitations.
• 6:26
  Dr.
• 6:26
  Tara Spires-Jones, a professor of neurodegeneration at the University of
• 6:31
  Edinburgh, noted that the study's reliance on self-reported sleep data could introduce bias,
• 6:37
  particularly among participants with memory issues.
• 6:40
  Additionally, the study's participant group was largely white, and the sample size was smaller
• 6:46
  than similar studies conducted at a single time point, which means further research is needed
• 6:50
  to confirm these findings.
• 6:53
  The researchers also pointed out that while their study's three-year duration is longer
• 6:57
  than some previous research, it is still relatively short.
• 7:02
  They highlighted the need to explore the mechanisms behind MCR further, as there are no
• 7:07
  definitive pathological biomarkers for the syndrome yet.
• 7:10
  Dr.
• 7:11
  Victoire Leroy, the first author of the study, suggested that sleep might play a role in
• 7:15
  cleaning neurotoxins from the brain, and noted that sleep-deprived individuals tend to have a
• 7:20
  greater accumulation of proteins associated with Alzheimer's disease.
• 7:24
  The study underscores the critical role sleep may play in brain health and dementia
• 7:29
  prevention.
• 7:30
  Dr.
• 7:31
  Isaacson advises those with sleep issues to consult their physicians, consider sleep
• 7:36
  questionnaires, and explore both drug and non-drug treatments.
• 7:40
  Maintaining good sleep health can have long-term benefits for brain health and might
• 7:44
  help in delaying or preventing dementia.
• 7:47
  In addition to addressing sleep issues, maintaining a healthy lifestyle—including a
• 7:52
  balanced diet, regular physical and mental activity, and addressing hearing loss—can help
• 7:58
  boost brain resilience and potentially lower dementia risk.
• 8:03
  While lifestyle choices can influence dementia risk, it's important to recognize that genetic
• 8:09
  factors play a significant role as well.
• 8:12
  Nevertheless, with ongoing research and advancements in medical treatments, there is
• 8:17
  hope in the fight against dementia.
• 8:20
  Today, we're exploring a significant shift in the medical community's perspective on
• 8:25
  work-life balance.
• 8:27
  A recent Wall Street Journal article has sparked intense discussion among physicians
• 8:31
  about the traditional 'workaholic' culture in medicine.
• 8:36
  For many years, doctors have prioritized their careers over personal life, often at the cost
• 8:42
  of personal well-being.
• 8:44
  However, a newer generation of physicians is questioning this long-standing norm, advocating
• 8:50
  for a more balanced approach that allows them to prioritize their own health and family life.
• 8:56
  The article highlights that this cultural shift is not without controversy.
• 9:01
  Some older doctors have criticized younger physicians for their push towards better
• 9:07
  work-life balance.
• 9:08
  However, many in the medical field, including Dr.
• 9:12
  Robert McNamara, Chair of Emergency Medicine at Temple University, argue that the traditional
• 9:17
  approach has led to negative outcomes, such as high suicide and divorce rates among doctors.
• 9:24
  Dr.
• 9:24
  McNamara believes it's unfair to expect the new generation to follow in the same footsteps that
• 9:29
  have proven detrimental to personal lives.
• 9:33
  Dr.
• 9:33
  Lewis Nelson, Chair of Emergency Medicine at Rutgers New Jersey Medical School, points out
• 9:38
  that the healthcare system itself has changed significantly.
• 9:42
  With more doctors employed by hospitals and health systems rather than owning their
• 9:46
  practices, there are new challenges like increased bureaucratic demands and reduced
• 9:50
  reimbursement for services.
• 9:53
  Dr.
• 9:53
  McNamara adds that when doctors were business owners, extra hours worked translated to
• 9:59
  personal rewards.
• 10:01
  Now, as employees, the added workload often benefits the institution more than the
• 10:07
  individual.
• 10:09
  This changing landscape has led some doctors to see themselves as employees rather than owners,
• 10:14
  adapting to the times as both the field of medicine and society evolve.
• 10:20
  Dr.
• 10:21
  Ali Haider, a cardiologist, notes that the autonomy physicians once enjoyed has diminished
• 10:28
  with the rise of corporate influence and administrative tasks.
• 10:32
  He emphasizes the necessity of adapting to these changes, as the practice of medicine and
• 10:37
  societal expectations have evolved.
• 10:41
  The notion of medicine as a 'calling' has also been reevaluated.
• 10:45
  Dr.
• 10:47
  Joel Katz, who has directed the residency program at Brigham and Women's Hospital for two
• 10:52
  decades, observes that the idea of work being a calling is now seen as potentially
• 10:59
  exploitative.
• 11:00
  Many young doctors no longer view their profession in this light, pushing back against
• 11:05
  the expectation to sacrifice personal well-being for their careers.
• 11:10
  Despite differing opinions, there is a consensus that a middle ground must be found.
• 11:17
  Dr.
• 11:17
  Joel Zivot, an anesthesiologist at Emory University, acknowledges that while young
• 11:22
  doctors are not lazy, they might be disillusioned if they seek happiness solely in
• 11:27
  balancing work and life.
• 11:31
  Dr.
• 11:31
  Nelson suggests that both the healthcare system and young physicians need to adjust their
• 11:36
  expectations and find ways to coexist in this new reality.
• 11:40
  Dr.
• 11:42
  Rachel Weinerman, a reproductive endocrinologist, offers practical solutions,
• 11:47
  advocating for flexible practice models that ensure excellent patient care while allowing
• 11:52
  for physician autonomy.
• 11:54
  She emphasizes that doctors will find satisfaction in their careers if they're fairly
• 11:58
  compensated and able to work to their full potential, minimizing administrative burdens.
• 12:05
  In the absence of these conditions, seeking autonomy and personal time becomes a necessary
• 12:11
  approach to combat burnout.
• 12:14
  As we turn our attention to the political landscape, former President Donald Trump's
• 12:18
  recent election victory is poised to bring significant changes to the healthcare system in
• 12:24
  the United States.
• 12:25
  His return to the White House is expected to scale back public health insurance programs,
• 12:31
  potentially increasing the uninsured rate and imposing new barriers to reproductive care.
• 12:38
  These changes could have far-reaching impacts, potentially eroding the Affordable Care Act's
• 12:43
  consumer protections and introducing work requirements in Medicaid, along with funding
• 12:48
  cuts to safety net insurance programs.
• 12:51
  In addition, with the elevation of vaccine skeptic Robert F.
• 12:55
  Kennedy Jr.
• 12:57
  within Trump's advisory circle, public health interventions backed by rigorous scientific
• 13:02
  research might face new challenges.
• 13:06
  This shift could weaken public confidence in established science and lead to an increase in
• 13:10
  preventable illnesses if debunked notions, such as a link between vaccines and autism, gain
• 13:16
  traction as policy decisions.
• 13:19
  Trump's administration is also likely to face immediate decisions on whether to support the
• 13:24
  extension of enhanced premium subsidies for Obamacare insurance plans.
• 13:29
  While Trump has stated he won't attempt to repeal the Affordable Care Act again, his
• 13:34
  administration might focus on minimizing fraud and waste, potentially slashing enrollment
• 13:39
  outreach funds and enabling the purchase of more health plans that don't comply with ACA
• 13:44
  consumer protections.
• 13:46
  This could lead to a rise in uninsured rates, as steep premium increases might deter
• 13:51
  enrollment.
• 13:53
  Trump supporters argue that he aims to improve the law to lower costs, pointing to his efforts
• 13:58
  during his first term to introduce price transparency in medical costs.
• 14:04
  Furthermore, Trump's administration may support preserving Medicare's authority to negotiate
• 14:10
  drug prices, a provision of the Inflation Reduction Act.
• 14:14
  Despite the drug industry's legal successes in blocking such programs, Trump's focus on
• 14:19
  reducing drug prices could lead to renewed efforts in this area.
• 14:24
  Leadership changes within health agencies are also anticipated, with figures like former
• 14:29
  Louisiana Governor Bobby Jindal and Seema Verma being considered for key positions.
• 14:36
  Medicaid, on the other hand, is likely to become a target for spending cuts, which could
• 14:41
  finance the extension of expiring tax breaks.
• 14:45
  Potential changes include imposing work requirements on beneficiaries and revamping how
• 14:50
  Medicaid is funded.
• 14:52
  Conservatives have long sought to cap federal allotments to states, a move critics argue
• 14:58
  would lead to significant cuts.
• 15:00
  As such, Medicaid could see substantial alterations under Trump's leadership.
• 15:06
  The future of reproductive health rights remains uncertain.
• 15:10
  While Trump has stated that abortion restrictions should be left to the states, he
• 15:14
  could move to restrict access to abortion medications.
• 15:18
  Currently, these medications are used in over half of abortions, and any federal withdrawal
• 15:24
  of authorization could severely limit their availability.
• 15:28
  Trump's administration may also reconsider the Comstock Act, which some interpret as banning
• 15:34
  the shipment of abortion drugs, though Trump has generally indicated he wouldn't use this
• 15:39
  law to ban mail delivery.
• 15:42
  In summary, as the Trump administration prepares to take office, the healthcare
• 15:46
  landscape in the United States faces potential upheaval.
• 15:50
  From changes in public health insurance programs to shifts in reproductive health
• 15:55
  policies, the next few years could see significant transformations.
• 15:59
  As always, we'll continue to monitor these developments closely and provide you with the
• 16:03
  latest updates and insights.
• 16:07
  Thank you for joining me today on Morning Medical with Dr.
• 16:10
  Chow.
• 16:11
  I hope you found today's discussions informative.
• 16:15
  Stay tuned for tomorrow's episode where we'll continue to explore the critical issues
• 16:20
  impacting health and medicine worldwide.
• 16:24
  Until then, take care and stay healthy.